MEDIGUS LTD. Inactive Instrument
Medigus Ltd. Share Price TEL AVIV STOCK EXCHANGE
Equities
IL0010961717
Advanced Medical Equipment & Technology
| Sales 2022 | 91.86M 339M 7.3B | Sales 2023 | 91.72M 339M 7.29B | Capitalization | 5.66M 20.89M 449M |
|---|---|---|---|---|---|
| Net income 2022 | -9M -33.24M -715M | Net income 2023 | -16M -59.1M -1.27B | EV / Sales 2022 | -0.08 x |
| Net cash position 2022 | 14.92M 55.09M 1.18B | Net cash position 2023 | 2.75M 10.16M 218M | EV / Sales 2023 | 0.03 x |
| P/E ratio 2022 |
-0.77
x | P/E ratio 2023 |
-0.34
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.23% |
More Fundamentals
* Assessed data
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Liron Carmel
CEO | Chief Executive Officer | 39 | 31/03/19 |
Tali Dinar
DFI | Director of Finance/CFO | 51 | 07/06/21 |
| Chief Tech/Sci/R&D Officer | 73 | 31/12/99 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Eliyahu Yoresh
CHM | Chairman | 54 | 31/08/18 |
Eli Cohen
BRD | Director/Board Member | 55 | 19/09/18 |
Ronen Rosenbloom
BRD | Director/Board Member | 52 | 19/09/18 |
Xylo Technologies Ltd, formerly known ad Medigus Ltd, is an Israel-based medical device company specializing in developing minimally invasive endosurgical tools and imaging solutions across medical and industrial applications. The Company developed a range of micro video cameras under micro ScoutCam portfolio of products and the Medigus Ultrasonic Surgical Endostapler, or MUSE system endoscopic device for the treatment of gastroesophageal reflux disease (GERD).
Calendar
01/09/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +12.06% | 227B | |
| +12.07% | 192B | |
| +13.88% | 136B | |
| +27.12% | 108B | |
| +0.91% | 64.07B | |
| +6.74% | 51.87B | |
| +13.39% | 52.1B | |
| +8.81% | 44.33B | |
| +4.14% | 36.75B |
